首页 | 官方网站   微博 | 高级检索  
     


19F NMR-Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter-Screens
Authors:Oliver Binas  Vanessa de Jesus  Tom Landgraf  Albrecht Eduard Völklein  Jason Martins  Daniel Hymon  Jasleen Kaur Bains  Hannes Berg  Thomas Biedenbänder  Dr Boris Fürtig  Dr Santosh Lakshmi Gande  Dr Anna Niesteruk  Andreas Oxenfarth  Dr Nusrat Shahin Qureshi  Tatjana Schamber  Robbin Schnieders  Alix Tröster  Dr Anna Wacker  Dr Julia Wirmer-Bartoschek  Maria Alexandra Wirtz Martin  Elke Stirnal  Dr Kamal Azzaoui  Dr Christian Richter  Dr Sridhar Sreeramulu  Dr Marcel Jules José Blommers  Prof Dr Harald Schwalbe
Affiliation:1. Institute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Johann Wolfgang Goethe-University Frankfurt, Max-von-Laue Strasse 7, 60438 Frankfurt am Main, Germany;2. Saverna Therapeutics, Gewerbestrasse 24, 4123 Allschwil, Switzerland
Abstract:We report here the nuclear magnetic resonance 19F screening of 14 RNA targets with different secondary and tertiary structure to systematically assess the druggability of RNAs. Our RNA targets include representative bacterial riboswitches that naturally bind with nanomolar affinity and high specificity to cellular metabolites of low molecular weight. Based on counter-screens against five DNAs and five proteins, we can show that RNA can be specifically targeted. To demonstrate the quality of the initial fragment library that has been designed for easy follow-up chemistry, we further show how to increase binding affinity from an initial fragment hit by chemistry that links the identified fragment to the intercalator acridine. Thus, we achieve low-micromolar binding affinity without losing binding specificity between two different terminator structures.
Keywords:DNA  19F  FBS  fluorine  fragment-based screening  proteins  RNA
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号